Epidermolysis Bullosa Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 752963|Published date: 13 November, 2024
Ependymoma Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 281751|Published date: 13 November, 2024
Eosinophilic Granulomatosis with Polyangiitis Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 701371|Published date: 13 November, 2024
Eosinophilic Esophagitis Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 401738|Published date: 13 November, 2024
End-Stage Renal Disease (ESRD) Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 849028|Published date: 13 November, 2024
Endometriosis Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 988324|Published date: 12 November, 2024
Encephalitis Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 382235|Published date: 12 November, 2024
Emphysema Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 274297|Published date: 12 November, 2024
Emesis Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 164862|Published date: 12 November, 2024
Embolotherapy Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 118815|Published date: 12 November, 2024
Eisenmenger Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 419426|Published date: 12 November, 2024
Dystrophic Epidermolysis Bullosa Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 336669|Published date: 11 November, 2024